🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

RSV hits the Netherlands hard in summer. What is happening? Where does the virus come from? How does it spread around the world?

1 billion doses today. But so much more to do.

Congrats to the BRONCHEU study team on their recent article publication in the Journal of Critical Care. BRONCHEU aims to investigate the amount & characteristics of #PICU admissions for viral bronchiolitis in Europe. Read publication here: bit.ly/3jgbnT6 #Paediatrics

Fundamental insight in community mortality by RSV. Ten upcoming papers in Clin Infect Dis discussed in the resvinet.org webinar on SEP-17 open for registration. #RSV #BMGF mcaevents.eventsair.com/resvinet-webin…

Painful lack of options to act. What can we do for our academic friends in Afghanistan?

RSV changes over time in the airways of infected babies.

Novel data about mortality due to RS-Virus outside the hospital. Register here to join FREE webinar on SEPT-17. #RSV #Fundacioninfant mcaevents.eventsair.com/resvinet-webin…

Very proud to share our new manuscript published in Clinical Infectious Diseases on #RSV-related infant community deaths! Many thanks to our amazing network of collaborators, we're truly grateful for all the time and efforts they put into our project! academic.oup.com/cid/article/73…

Really excited to be working with leading #RSV scientists in Europe to pave the way for introduction of novel vaccines and therapeutics against RSV. PROMISE Project builds on the successes of RESCEU Project over past 5 years. John Paget, PhD Hanna Nohynek Andrew Pollard Peter Openshaw Louis Bont

The UMC Utrecht, @RIVM and @Nivel_research are proud partners within the new EU PROMISE network which will focus on RS virus spread patterns. It will also monitor effects of interventions that help to defend against #RSV (such as vaccination) bit.ly/3k2XiJP Louis Bont

The patient perspective first in the next EU-funded RSV project PROMISE. #RSV @NairHarish Hanna Nohynek Andrew Pollard Peter Openshaw.

Today is the start of ReSViNET’s 6th conference RSVVW’21 – “A Global Conference on Novel RSV Preventive and Therapeutic Interventions”! 👉resvinet.org/rsvvw21.html #RSV #ReSViNET

RSV immunizations enter the endgame. We must consider how to deliver them to those who need them most. By Ginsburg & Srikantiah thelancet.com/journals/langl…. #RSV #BMGF # ReSViNET

Worldwide hospital-acquired RSV infection causes 20% of all hospital RSV deaths. #RSV #BMGF medrxiv.org/content/10.110…

RSV vaccine development reaches endgame. #RSV #BMGF RSV vaccine development reaches endgame. sciencedirect.com/science/articl….

I recently wrote a piece on what you need to know about #RSV. I discuss why RSV is surging now, where it is most deadly and why I’m optimistic that there may soon be a vaccine to protect children from this dangerous illness. Read more 👇

AddThis | Home authors.elsevier.com/a/1g3d07tFB1Q3…

AddThis | Home authors.elsevier.com/a/1gWle,60n7o9…